Related Experiment Video

Updated: Feb 15, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.7K

Comparisons of three different doses of alirocumab application in patients with hypercholesterolemia: a meta-analysis

Yu-Sheng Zhang1, Ye-Hua Hao1, Hou-Long Luo2

  • 1Department of Pharmacy, Guangdong Medical University, Guangdong, China.

Minerva Medica
|January 16, 2018
PubMed

Insights

The 75-150 mg dose of alirocumab every two weeks is most effective for lowering LDL cholesterol and increasing HDL cholesterol in hypercholesterolemia patients. This dosage is preferred over other alirocumab regimens for managing high cholesterol.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Clinical Trials

Background:

  • Low high-density lipoprotein cholesterol (HDL-C) and high low-density lipoprotein cholesterol (LDL-C) are risk factors for cardiovascular disease (CVD).
  • Alirocumab is a promising therapeutic agent for hypercholesterolemia.
  • Optimizing alirocumab dosage is crucial for effective CVD risk management.

Purpose of the Study:

  • To compare the efficacy of three different doses of alirocumab in patients with hypercholesterolemia.
  • To determine the optimal alirocumab dosage regimen for lipid-lowering.
  • To evaluate the impact of different alirocumab doses on lipid profiles and treatment goals.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials.
  • Searched major databases including PubMed, EMBASE, PMC, and Cochrane Library.
  • Subgroup analysis was used to compare different alirocumab doses (75-150 mg Q2W, 300 mg Q4W, 150 mg Q2W).

Main Results:

  • Nine studies with 3870 patients were analyzed.
  • Alirocumab 75-150 mg every two weeks (Q2W) significantly reduced LDL-C (MD, -55.17%) and increased HDL-C (MD, 7.70%) compared to other doses.
  • No significant differences were observed in achieving LDL-C treatment goals (≤1.8 mmol/L), other lipid parameters, or adverse event incidence.

Conclusions:

  • The alirocumab dosage of 75-150 mg Q2W is superior for improving LDL-C and HDL-C levels in hypercholesterolemia.
  • This dosage regimen is recommended for patients requiring alirocumab therapy.
  • Further research may explore long-term outcomes and specific patient subgroups.
Abstract

More Related Videos

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images SDM-PSI

Published on: November 27, 2019

77.9K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.2K

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
280
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
270
Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.1K
The Sense of Self: Reflected Self-Appraisal and Social Comparison02:57

The Sense of Self: Reflected Self-Appraisal and Social Comparison

According to Charles Cooley, we base our image on what we think other people see (Cooley 1902). We imagine how we must appear to others, then react to this speculation. We don certain clothes, prepare our hair in a particular manner, wear makeup, use cologne, and the like—all with the notion that our presentation of ourselves is going to affect how others perceive us. We expect a certain reaction, and, if lucky, we get the one we desire and feel good about it. But more than that, Cooley...
56.2K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
345
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
268